Activity of purified hepatitis C virus protease NS3 on peptide substrates
- PMID: 8794305
- PMCID: PMC190711
- DOI: 10.1128/JVI.70.10.6694-6700.1996
Activity of purified hepatitis C virus protease NS3 on peptide substrates
Abstract
The protease domain of the hepatitis C virus (HCV) protein NS3 was expressed in Escherichia coli, purified to homogeneity, and shown to be active on peptides derived from the sequence of the NS4A-NS4B junction. Experiments were carried out to optimize protease activity. Buffer requirements included the presence of detergent, glycerol, and dithiothreitol, pH between 7.5 and 8.5, and low ionic strength. C- and N-terminal deletion experiments defined a peptide spanning from the P6 to the P4' residue as a suitable substrate. Cleavage kinetics were subsequently measured by using decamer P6-P4' peptides corresponding to all intermolecular cleavage sites of the HCV polyprotein. The following order of cleavage efficiency, in terms of kcat/Km, was determined: NS5A-NS5B > NS4A-NS4B >> NS4B-NS5A. A 14-mer peptide containing residues 21 to 34 of the protease cofactor NS4A (Pep4A 21-34), when added in stoichiometric amounts, was shown to increase cleavage rates of all peptides, the largest effect (100-fold) being observed on the hydrolysis of the NS4B-NS5A decamer. From the kinetic analysis of cleavage data, we conclude that (i) primary structure is an important determinant of the efficiency with which each site is cleaved during polyprotein processing, (ii) slow cleavage of the NS4B-NS5A site in the absence of NS4A is due to low binding affinity of the enzyme for this site, and (iii) formation of a 1:1 complex between the protease and Pep4A 21-34 is sufficient and required for maximum activation.
Similar articles
-
Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.Biochemistry. 1999 Apr 27;38(17):5620-32. doi: 10.1021/bi982892+. Biochemistry. 1999. PMID: 10220351
-
In vitro activity of hepatitis C virus protease NS3 purified from recombinant Baculovirus-infected Sf9 cells.J Biol Chem. 1996 Mar 15;271(11):6367-73. doi: 10.1074/jbc.271.11.6367. J Biol Chem. 1996. PMID: 8626434
-
The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.Antivir Ther. 1998;3(Suppl 3):99-109. Antivir Ther. 1998. PMID: 10726060 Review.
-
Product inhibition of the hepatitis C virus NS3 protease.Biochemistry. 1998 Jun 23;37(25):8899-905. doi: 10.1021/bi980313v. Biochemistry. 1998. PMID: 9636031
-
Processing pathways of the hepatitis C virus proteins.J Hepatol. 1996;24(2 Suppl):11-9. J Hepatol. 1996. PMID: 8836884 Review.
Cited by
-
Conserved C-terminal threonine of hepatitis C virus NS3 regulates autoproteolysis and prevents product inhibition.J Virol. 2004 Jan;78(2):700-9. doi: 10.1128/jvi.78.2.700-709.2004. J Virol. 2004. PMID: 14694101 Free PMC article.
-
Protease inhibitors as antiviral agents.Clin Microbiol Rev. 1998 Oct;11(4):614-27. doi: 10.1128/CMR.11.4.614. Clin Microbiol Rev. 1998. PMID: 9767059 Free PMC article. Review.
-
Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2992-7. doi: 10.1073/pnas.0408824102. Epub 2005 Feb 14. Proc Natl Acad Sci U S A. 2005. PMID: 15710891 Free PMC article.
-
Characterization of engineered hepatitis C virus NS3 protease inhibitors affinity selected from human pancreatic secretory trypsin inhibitor and minibody repertoires.J Virol. 1997 Oct;71(10):7461-9. doi: 10.1128/JVI.71.10.7461-7469.1997. J Virol. 1997. PMID: 9311825 Free PMC article.
-
Conformational changes in the NS3 protease from hepatitis C virus strain Bk monitored by limited proteolysis and mass spectrometry.Protein Sci. 1999 Jul;8(7):1445-54. doi: 10.1110/ps.8.7.1445. Protein Sci. 1999. PMID: 10422832 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous